AU633859B2 - Improvements in or relating to organic compounds - Google Patents

Improvements in or relating to organic compounds Download PDF

Info

Publication number
AU633859B2
AU633859B2 AU45871/89A AU4587189A AU633859B2 AU 633859 B2 AU633859 B2 AU 633859B2 AU 45871/89 A AU45871/89 A AU 45871/89A AU 4587189 A AU4587189 A AU 4587189A AU 633859 B2 AU633859 B2 AU 633859B2
Authority
AU
Australia
Prior art keywords
group
somatostatin
peptide
hydrogen
cys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU45871/89A
Other languages
English (en)
Other versions
AU4587189A (en
Inventor
Rainer Albert
Eric P. Krenning
Steven W.J. Lamberts
Janos Pless
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888828364A external-priority patent/GB8828364D0/en
Priority claimed from GB898916115A external-priority patent/GB8916115D0/en
Priority claimed from GB898916761A external-priority patent/GB8916761D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU4587189A publication Critical patent/AU4587189A/en
Application granted granted Critical
Publication of AU633859B2 publication Critical patent/AU633859B2/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG Request to Amend Deed and Register Assignors: SANDOZ LTD.
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU45871/89A 1988-12-05 1989-12-04 Improvements in or relating to organic compounds Expired AU633859B2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB888828364A GB8828364D0 (en) 1988-12-05 1988-12-05 Improvements in/relating to organic compounds
GB898916115A GB8916115D0 (en) 1989-07-13 1989-07-13 Improvements in or relating to organic compounds
GB8916115 1989-07-21
GB8916761 1989-07-21
GB898916761A GB8916761D0 (en) 1989-07-21 1989-07-21 Improvements in or relating to organic compounds
GB8828364 1989-07-21

Publications (2)

Publication Number Publication Date
AU4587189A AU4587189A (en) 1990-06-14
AU633859B2 true AU633859B2 (en) 1993-02-11

Family

ID=27264222

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45871/89A Expired AU633859B2 (en) 1988-12-05 1989-12-04 Improvements in or relating to organic compounds

Country Status (24)

Country Link
JP (2) JP2726320B2 (de)
KR (1) KR0156541B1 (de)
AT (1) AT403476B (de)
AU (1) AU633859B2 (de)
BE (1) BE1002296A5 (de)
CA (1) CA2004532C (de)
CH (1) CH678329A5 (de)
DE (1) DE3991505B4 (de)
DK (1) DK175338B1 (de)
ES (1) ES2023533A6 (de)
FI (1) FI102540B1 (de)
FR (1) FR2639947B1 (de)
GB (1) GB2225579B (de)
HK (1) HK189995A (de)
HU (2) HUT53375A (de)
IE (1) IE62091B1 (de)
IL (1) IL92534A (de)
LU (1) LU87633A1 (de)
MY (1) MY106120A (de)
NL (1) NL194828C (de)
PT (1) PT92487B (de)
SA (1) SA96160495B1 (de)
SE (1) SE508799C2 (de)
WO (1) WO1990006949A2 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU639371B2 (en) * 1987-07-10 1993-07-22 Novartis Ag Method of treating breast cancer
DE3822557C2 (de) * 1987-07-10 1998-07-02 Ciba Geigy Ag Arzneimittel, enthaltend Somatostatine
GB9111199D0 (en) * 1991-05-23 1991-07-17 Sandoz Ltd Improvements in or relating to organic compounds
US5700444A (en) * 1992-02-20 1997-12-23 Rhomed Incorporated Chemotactic peptide pharmaceutical applications
US5985240A (en) * 1989-08-09 1999-11-16 Rhomed Incorporated Peptide radiopharmaceutical applications
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
US5460785A (en) * 1989-08-09 1995-10-24 Rhomed Incorporated Direct labeling of antibodies and other protein with metal ions
GB9004017D0 (en) * 1990-02-22 1990-04-18 Krenning Eric P Improvements in or relating to organic compounds
US5382654A (en) * 1992-02-05 1995-01-17 Mallinckrodt Medical, Inc. Radiolabelled peptide compounds
US7238340B1 (en) 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
ATE181240T1 (de) * 1991-02-08 1999-07-15 Biomeasure Inc Verwendung von somatostatinanalogen zur behandlung von melanomen
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
CA2102633A1 (en) * 1991-06-03 1992-12-04 Peter H. Cox Radiolabelled somatostatin derivatives, their preparation and use
AU2462592A (en) * 1991-08-29 1993-04-05 Mallinckrodt Medical, Inc. Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins
US5225180A (en) * 1991-09-10 1993-07-06 Diatech, Inc. Technetium-99m labeled somatostatin-derived peptides for imaging
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
US5738838A (en) * 1992-02-20 1998-04-14 Rhomed Incorporated IKVAV peptide radiopharmaceutical applications
US5556609A (en) * 1992-02-20 1996-09-17 Rhomed Incorporated YIGSR peptide radiopharmaceutical applications
DK0629133T3 (da) * 1992-01-03 2001-04-02 Rhomed Inc Farmaceutisk anvendelse af peptidmetalioner
US5371184A (en) * 1992-02-05 1994-12-06 Mallinckrodt Medical, Inc. Radiolabelled peptide compounds
JPH08504166A (ja) * 1992-02-05 1996-05-07 マリンクロッド・メディカル・インコーポレイテッド 放射標識ペプチド化合物
US5643549A (en) * 1992-02-20 1997-07-01 Rhomed Incorporated Leukostimulatory agent for in vivo leukocyte tagging
AU3967593A (en) * 1992-03-25 1993-10-21 Mallinckrodt Medical, Inc. Method of intraoperatively detecting and locating tumoral tissues
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
US5871711A (en) * 1992-06-23 1999-02-16 Diatide, Inc. Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses
US5620675A (en) * 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US5650134A (en) * 1993-01-12 1997-07-22 Novartis Ag (Formerly Sandoz Ltd.) Peptides
FI940109A (fi) * 1993-01-12 1994-10-11 Sandoz Ag Peptidejä
EP0683676A4 (de) * 1993-02-02 1998-09-30 Neorx Corp Gelenkte bioverteilung von kleinen molekülen.
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
US5932189A (en) * 1994-07-29 1999-08-03 Diatech, Inc. Cyclic peptide somatostatin analogs
SG93839A1 (en) * 1993-07-15 2003-01-21 Diatide Inc Radiolabeled peptides
CA2190727C (en) * 1994-05-19 2006-07-18 Sudhakar Kasina Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
GB9417873D0 (en) * 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds
US5632969A (en) * 1994-10-13 1997-05-27 Merck & Co., Inc. N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications
US5556939A (en) * 1994-10-13 1996-09-17 Merck Frosst Canada, Inc. TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
US5830431A (en) * 1995-06-07 1998-11-03 Mallinckrodt Medical, Inc. Radiolabeled peptide compositions for site-specific targeting
GB9708265D0 (en) 1997-04-24 1997-06-18 Nycomed Imaging As Contrast agents
FI965181A (fi) * 1996-12-20 1998-06-21 Map Medical Technologies Oy Polyalkoholi-peptidijohdannaiset
DE19917713A1 (de) * 1999-04-09 2000-10-19 Diagnostikforschung Inst Kurzkettige Peptid-Farbstoffkonjugate als Konstrastmittel für die optische Diagnostik
US7175953B2 (en) 1999-04-09 2007-02-13 Institute Fuer Diagnostik Forschung Short-warp peptide-dye conjugate as contrast agent for optical diagnostic
US6630570B1 (en) 1999-04-09 2003-10-07 Insitut für Diagnostikforschung GmbH Short-chain peptide-dye conjugates as contrast media for optical diagnosis
US6685914B1 (en) 1999-09-13 2004-02-03 Bristol-Myers Squibb Pharma Company Macrocyclic chelants for metallopharmaceuticals
HU228811B1 (hu) 2001-04-23 2013-05-28 Mallinckrodt Llc Technéciummal és réniummal radioaktívan jelölt, glikozilált oktreotidszármazékok
CN100475271C (zh) 2003-08-20 2009-04-08 加利福尼亚大学董事会 具有抑制生长激素释放活性的促生长素抑制素类似物
EP2474328A3 (de) * 2003-09-17 2012-07-18 Board Of Regents, The University Of Texas System Mechanismusbasierte gezielte pankreatische Betazellenabbildung und Behandlung
EP2067786A1 (de) 2007-12-07 2009-06-10 ITALFARMACO S.p.A. Neue nichtselektive Analoga von Somatostatin
EP2922578B1 (de) 2012-11-21 2018-12-12 Serene, Llc Tin-117m-somatostatinrezeptor-bindende verbindungen

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5184886A (en) * 1985-01-07 1986-07-10 Sandoz Ltd. Somatostatines
AU4453589A (en) * 1988-11-11 1990-05-17 Sandoz Ltd. Improvements in or relating to organic compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1222691A (en) * 1981-12-29 1987-06-09 Wilhelmus T. Goedemans Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments
US4652519A (en) * 1983-02-03 1987-03-24 Yeda Research And Development Company Limited Bifunctional chelating agents and process for their production
US4707352A (en) * 1984-01-30 1987-11-17 Enzo Biochem, Inc. Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group
DE3511206A1 (de) * 1985-03-28 1986-10-09 Sandoz-Patent-GmbH, 7850 Lörrach Neue polypeptidderivate, ihre herstellung und pharmazeutische praeparate, welche diese polypeptidderivate enthalten
DE3522638A1 (de) * 1985-06-25 1987-01-08 Diamalt Ag Neue somatostatin-derivate
US4678667A (en) * 1985-07-02 1987-07-07 501 Regents of the University of California Macrocyclic bifunctional chelating agents
CA1266344A (en) * 1986-02-14 1990-02-27 Miki Kurami High molecular compounds having amino groups, and their utilization
US4732974A (en) * 1986-03-05 1988-03-22 Mallinckrodt, Inc. Metal ion labeling of carrier molecules
US4861869A (en) * 1986-05-29 1989-08-29 Mallinckrodt, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
HU206890B (en) * 1986-10-13 1993-01-28 Sandoz Ag Process for producing sugar-modified somatostatin peptide derivatives and pharmaceutical compositions containing them as active components
CH679045A5 (de) * 1987-06-29 1991-12-13 Sandoz Ag
US5073541A (en) * 1987-11-18 1991-12-17 Administrators Of The Tulane Educational Fund Treatment of small cell lung cancer with somatostatin analogs

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5184886A (en) * 1985-01-07 1986-07-10 Sandoz Ltd. Somatostatines
AU4453589A (en) * 1988-11-11 1990-05-17 Sandoz Ltd. Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
IE62091B1 (en) 1994-12-14
FI102540B (fi) 1998-12-31
BE1002296A5 (fr) 1990-11-20
JP2726320B2 (ja) 1998-03-11
NL194828C (nl) 2003-04-03
NL194828B (nl) 2002-12-02
MY106120A (en) 1995-03-31
JP3686503B2 (ja) 2005-08-24
CH678329A5 (de) 1991-08-30
PT92487B (pt) 1996-01-31
HK189995A (en) 1995-12-29
AU4587189A (en) 1990-06-14
KR0156541B1 (ko) 1998-10-15
LU87633A1 (fr) 1991-09-18
NL8902981A (nl) 1990-07-02
FI895809A0 (fi) 1989-12-04
FI102540B1 (fi) 1998-12-31
CA2004532C (en) 2000-02-22
GB8927255D0 (en) 1990-01-31
WO1990006949A3 (en) 1990-07-26
KR900009697A (ko) 1990-07-05
HUT53375A (en) 1990-10-28
CA2004532A1 (en) 1990-06-05
IL92534A (en) 1994-06-24
FR2639947B1 (fr) 1995-04-21
DK612689D0 (da) 1989-12-05
DK175338B1 (da) 2004-08-30
PT92487A (pt) 1990-06-29
JPH02184698A (ja) 1990-07-19
DE3991505B4 (de) 2006-04-20
DK612689A (da) 1990-06-06
HU896359D0 (en) 1990-02-28
ES2023533A6 (es) 1992-01-16
GB2225579B (en) 1993-03-17
FR2639947A1 (fr) 1990-06-08
SE508799C2 (sv) 1998-11-09
ATA901789A (de) 1997-07-15
HU211468A9 (en) 1995-11-28
AT403476B (de) 1998-02-25
IE893866L (en) 1990-06-05
WO1990006949A2 (en) 1990-06-28
SE8904087L (sv) 1991-06-05
JPH1095737A (ja) 1998-04-14
SA96160495B1 (ar) 2006-08-23
GB2225579A (en) 1990-06-06
SE8904087D0 (sv) 1989-12-04

Similar Documents

Publication Publication Date Title
AU633859B2 (en) Improvements in or relating to organic compounds
EP0436005B1 (de) Markierte polypeptidderivate
AU714447B2 (en) Somatostatin peptides
US5650134A (en) Peptides
JPH08503924A (ja) 造影および治療用途の放射性標識ソマトスタチン誘導ペプチド
EP0831938B1 (de) Mittel auf basis radiomarkierter peptide zur ortsspezifischen verabreichung
CA2069154C (en) Polypeptides
US5776894A (en) Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors
US5686410A (en) Polypeptide derivatives
US5753627A (en) Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis
SK2094A3 (en) Somatostatine polypeptides, method of their preparing and using
US6123916A (en) Therapeutic use of somatostatin peptides
WO1995020603A1 (en) Inhibitors of serine proteases, bearing a chelating group
FI101967B (fi) Menetelmä farmaseuttisesti käyttökelpoisen radionuklidin kanssa komple ksoidun ligandin valmistamiseksi
PL163432B1 (pl) Sposób wytwarzania nowych pochodnych peptydu somatostatyny PL PL PL PL